Status:
WITHDRAWN
Urica Cor Intervention (URICORI) Trial
Lead Sponsor:
Torkell Ellingsen
Collaborating Sponsors:
Odense University Hospital
Frederiksberg University Hospital
Conditions:
Gout
Cardiovascular Diseases
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The objective of the Urica Cor Intervention (URICORI) trial is to evaluate the effectiveness of a one-year, intervention of modifiable risk factors for CVD administered in a rheumatology outpatient cl...
Detailed Description
Introduction: Gout has been associated with a number of comorbidities including cardiovascular disease (CVD). Mounting evidence suggests that hyperuricaemia and gout are associated with a high risk fo...
Eligibility Criteria
Inclusion
- Gout according to current EULAR/ACR (American College of Rheumatology) gout classification criteria
- Age \>18 years
- Plasma LDL \>3.0 mmol/L
- Agreeable to start treatment for CVD risk factors if indicated
- Ability to give informed consent
- Ability to communicate via telephone
Exclusion
- Other inflammatory diseases requiring immunosuppressant therapy.
- Age \>70 years.
- Active cancer (in active treatment).
- Chronic kidney disease (eGFR \<30 ml/min/1.73m2).
- People whose behaviour or lifestyle would render them less likely to comply with the study protocol (i.e., abuse of alcohol, substance misuse or debilitating psychiatric conditions).
- Familial hypercholesterolemia.
Key Trial Info
Start Date :
November 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04459936
Start Date
November 24 2020
End Date
February 1 2022
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital
Odense, Denmark, 5000